QT Vascular: Indications Of Interest Of Coronary Assets.

16 Oct 2017 - ShareInvestor Express
QT Vascular Ltd. has received indications of interest in relation to a potential transaction relating to, inter alia, the Company's coronary assets. The indications of interest are non-legally binding and non-definitive...
sgx:5i0

---

Hot Stock: QT Vascular jumps on hopes of asset sale

16 Oct 2017 - Business Times Breaking News
SHARES of QT Vascular, a maker of coronary products, surged on Monday amid hopes over a "potential transaction" linked to certain coronary assets as announced over the weekend. The stock rose 0.1 Singapore cent to 1.2 Singapore cents with some 34 million shares changing hands as at 9.25am, making it ...
sgx:5i0

---

QT Vascular: Update On Manufacturing Transfer.

4 Sep 2017 - ShareInvestor Express
QT Vascular Ltd. has substantially completed the manufacturing transfer of its Chocolate PTA product to Emerald Apex Pte Ltd, a third-party contract manufacturer, in Singapore. The Company expects that in the coming weeks, the necessary documentation will be verified and the transfer will be deemed completed. ...
sgx:5i0

---

QT Vascular: 2Q2017 Revenue Increases 47.8% To US$3.5 Million.

10 Aug 2017 - ShareInvestor Express
Number of units sold continues to rise each quarter. Commencement of FDA approved pivotal trial for Chocolate Touch, its drug-coated peripheral balloon...
sgx:5i0

---

QT Vascular: Begins Enrollment In US Pivotal Study Of Its Drug-Coated Peripheral Balloon.

31 Jul 2017 - ShareInvestor Express
QT Vascular Ltd. has started enrollment in its United States pivotal clinical study. The study will evaluate the Company's drug coated balloon, the Chocolate Touch, for use in superficial femoral and popliteal arteries with the intention of obtaining a US regulatory approval. The co-principal investigators ...
sgx:5i0

---

QT Vascular: Signs MOU With HK-Listed China VAST & SJZ High-Tech Zone To Explore Opportunities In China.

4 Jul 2017 - ShareInvestor Express
Areas of cooperation include project development, biotechnology sharing, talent exchange and fund raising...
sgx:5i0

---

QT Vascular: Announces 24-Month Angiographic Data For Chocolate Heart Drug-Coated Coronary Balloon.

21 Jun 2017 - ShareInvestor Express
QT Vascular Ltd. has received angiographic data from 24-month follow-up of patients with De Novo lesions treated with Chocolate Heart as a standalone therapy. The initial six-month results were announced on 5 January 2016...
sgx:5i0

---

QT Vascular to hold EGM on June 2 on proposed sale of catheter product

18 May 2017 - Business Times Breaking News
QT Vascular will conduct an extraordinary general meeting on June 2 to seek shareholder approval to sell its non-drug coated balloon catheter product to Medtronic Inc.The company, which specialises in developing catheter products, said on May 12 that it had agreed to a deal that gives Medtronic the option ...
sgx:5i0

---

QT Vascular to sell non-drug coated product to Medtronic for US$28m

12 May 2017 - Business Times Breaking News
QT Vascular said on Friday it has agreed to sell its non-drug coated Chocolate PTA to Medtronic for US$28 million.The option agreement was inked on Thursday between the group and two subsidiaries and Medtronic Inc and one of its affiliates. The option is exercisable within 90 days upon achievement of ...
sgx:5i0

---

QT Vascular: Enters Into Asset Purchase Option Agreement With Medtronic.

12 May 2017 - ShareInvestor Express
Medtronic has the option to purchase QT Vascular's non-drug coated Chocolate PTA. Option recognizes the value of this internally developed specialty PTA to improve patient outcomes...
sgx:5i0

---